Trump Administration Reportedly Drafting Executive Order to Centralize NIH Grant Oversight

Baltimore, MD, September 21, 2026 — Reports indicate that the Trump administration is developing an executive order aimed at centralizing the National Institutes of Health (NIH) grant approval processes. The proposed measure, if enacted, would place the authority for approving these grants under the purview of political appointees within the White House, thereby increasing direct presidential oversight.

The initiative, as suggested by preliminary reports, seeks to consolidate decision-making power regarding research funding. Currently, the NIH operates with a system that involves extensive review by scientific experts to determine the merit and feasibility of grant proposals. The potential shift could alter this established process by introducing a layer of political appointees into the final approval stages.

Specific details regarding the scope of the executive order, the exact roles of the political appointees, or the precise timeline for its potential implementation have not yet been fully disclosed. The contractor or agency responsible for drafting the order was not immediately specified in the reports.

Centralizing grant approval under political appointees could lead to significant changes in how federal research funding is allocated and managed. Proponents might argue it aligns research priorities with national objectives, while critics could raise concerns about the potential for politicization of scientific funding decisions, impacting the independence of research and the peer-review process.

The National Institutes of Health is a bureau within the U.S. Department of Health and Human Services and is responsible for conducting and supporting fundamental biomedical and behavioral research. Its grants fund a vast array of research projects across universities, medical centers, and other research institutions throughout the United States and internationally, playing a critical role in advancing medical knowledge and public health.

Further information regarding the specific provisions of the drafted executive order, its potential impact on the NIH’s operations, and any public comment periods or legislative reviews that may follow is anticipated as developments unfold. The outcome and nature of the final order remain subject to the administration’s final decisions and any potential challenges.

Story summarized from the original created by Joseph Choi on thehill.com, see more information here.

Media gallery